Vivesto is a specialty pharmaceutical company focused on the development of new therapeutic options for patients suffering from hard-to-treat cancers.
Non Regulatory May 18, 2022Invitation to presentation of Vivesto’s Q1 report 2022 on May 25
Regulatory April 29, 2022New number of shares and votes in Vivesto
Regulatory April 28, 2022Correction: Vivesto publishes Annual Report for 2021
Vivesto will publish its Q1 report for 2022 on May 25, 2022, at 08.00 am CET. The company will hold a conference call and an online presentation on the same day at 10.00 am CET. The call will be hosted by CEO Francois Martelet and CFO Fredrik Järrsten. The presentation will be in English and followed by a question-and-answer session.